Most Recent Publications
The Keri Lab has a record of publishing research in high-impact, peer-reviewed journals. Below are the 5 most recent publications from our lab. The National Center for Biotechnology Information contains an up-to-date list of all of our publications.
Targeting YES1 disrupts mitotic fidelity and potentiates the response to taxanes in triple-negative breast cancer
Piemonte KM, Ingles NN, Weber Bonk KL, Valentine MJ, Majmudar PR, Singh S, Keri RA. Cancer Research. 2024 Jul 22. doi: 10.1158/0008-5472.CAN-23-2558.
Chromatin organization and transcriptional programming of breast cancer cell identity
Bobbitt JR, Seachrist D, Keri RA. Endocrinology. 2023 Jul 3. doi: 10.1210/endocr/bqad100.
Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction
Piemonte KM, Webb BM, Bobbitt JR, Majmudar PR, Cuellar-Vite L, Bryson BL, Latina NC, Seachrist DD, Keri RA. J Biol Chem. 2023 May 17. doi: 10.1016/j.jbc.2023.104834.
TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis
Anstine LJ, Majmudar PR, Aponte A, Singh S, Zhao R, Weber Bonk KL, Abdul-Karim FW, Valentine M, Seachrist DD, Grenell-Nickelson KE, Cuellar-Vite L, Sizemore GM, Sizemore ST, Webb BM, Thompson CL, Keri RA. Cancer Research. 2023 Jan 25. doi: 10.1158/0008-5472.CAN-22-3133.
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
Seachrist DD, Anstine LJ, Keri RA. Cancers. 2021 Oct 17. doi: 10.3390/cancers13205205.